n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with sildenafil citrate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brun, BF; Campos-Toimil, M; Dias, AT; Gava, AL; Gil-Longo, J; Leal, MAS; Meyrelles, SS; Pereira, TMC; Porto, ML; Vasquez, EC | 1 |
1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and sildenafil citrate
Article | Year |
---|---|
Sildenafil (Viagra®) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE-/- Mice.
Topics: Animals; Apolipoproteins E; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Interleukin-10; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrobenzenes; Phenylephrine; Pyrazoles; Receptors, Thromboxane; Sildenafil Citrate; Sulfonamides; Thromboxane A2; Vasoconstriction | 2017 |